News from aratana therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 11, 2019, 16:05 ET Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for ...


May 07, 2019, 08:00 ET Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for ...


Apr 26, 2019, 06:28 ET Aratana Therapeutics to be Acquired by Elanco Animal Health

Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats,...


Feb 04, 2019, 07:45 ET Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for ...


Jan 17, 2019, 20:53 ET Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Nov 01, 2018, 16:05 ET Aratana Therapeutics Reports Third Quarter 2018 Financial Results

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Aug 29, 2018, 08:30 ET Aratana Therapeutics to Present at CL King and Associates Best Ideas Conference

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Aug 02, 2018, 16:05 ET Aratana Therapeutics Reports Second Quarter 2018 Financial Results

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Jul 10, 2018, 08:30 ET Aratana Therapeutics to Report Second Quarter 2018 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Jun 01, 2018, 08:30 ET Aratana Therapeutics Files for FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) Label Expansion

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


May 03, 2018, 04:05 ET Aratana Therapeutics Reports First Quarter 2018 Financial Results

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Apr 12, 2018, 08:30 ET Aratana Therapeutics to Report First Quarter 2018 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Apr 05, 2018, 09:29 ET Aratana Therapeutics Confirms Receipt of Board Nominations

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Mar 01, 2018, 08:30 ET Aratana Therapeutics Expands Therapeutic Candidate Pipeline

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Feb 13, 2018, 08:30 ET Aratana Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Jan 18, 2018, 08:00 ET GALLIPRANT® (grapiprant tablets) Named Best Companion Animal Product for 2017

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Jan 11, 2018, 08:20 ET Elanco, Aratana Announce Marketing Authorization of GALLIPRANT® (grapiprant tablets) in Europe

Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY) and Aratana Therapeutics, Inc. (NASDAQ: PETX), today announced the European...


Apr 14, 2016, 04:05 ET Aratana Therapeutics to Report First Quarter 2016 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Nov 28, 2014, 10:52 ET Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of...


Dec 11, 2013, 04:03 ET Aratana Therapeutics to Participate in Upcoming Investor Events

Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative...


Oct 01, 2013, 07:00 ET Aratana Therapeutics Added to Russell Indexes

Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of...


Sep 27, 2013, 07:38 ET Aratana Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference

Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of...


Sep 05, 2013, 09:00 ET Aratana Therapeutics to Present at Two Upcoming Investor Conferences

Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of...


Sep 03, 2013, 09:00 ET Aratana Therapeutics Drives Awareness of Pet Therapeutic Opportunity During "CVC Week" in Kansas City

Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of...


Aug 29, 2013, 09:00 ET Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event

Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of...